Figure 7.

Representative immunoblots for NET and GAPDH (A). Relative quantification of immunoblot density between groups 8 weeks after STZ or vehicle administration (B). Mean ± SD. * p < 0.05 to controls, † p < 0.05 to euglycemic, two-tailed t-test.

Thackeray et al. Cardiovascular Diabetology 2011 10:75   doi:10.1186/1475-2840-10-75
Download authors' original image